[1]
N. Ashoush, “ECONOMIC EVALUATION OF IMIPENEM-CILASTATIN VERSUS DORIPENEM IN VENTILATORASSOCIATED PNEUMONIA IN EGYPT”, Asian J Pharm Clin Res, vol. 10, no. 6, pp. 406–410, Jun. 2017.